1. Acta Neuropathol Commun. 2019 Jul 9;7(1):110. doi: 10.1186/s40478-019-0763-x.

An unusual recurrent high-grade glioneuronal tumor with MAP2K1 mutation and 
CDKN2A/B homozygous deletion.

Cheaney B 2nd(1), Bowden S(2), Krause K(2), Sloan EA(3), Perry A(3), Solomon 
DA(3), Han SJ(2), Wood MD(4).

Author information:
(1)School of Medicine, Oregon Health & Science University, Portland, Oregon, 
USA.
(2)Department of Neurological Surgery, Oregon Health & Science University, 
Portland, Oregon, USA.
(3)Department of Pathology, University of California San Francisco, San 
Francisco, California, USA.
(4)Department of Pathology, Oregon Health & Science University, Mail Code L-113, 
3181 SW Sam Jackson Park Road, Portland, OR, 97202, USA. woodmat@OHSU.edu.

DOI: 10.1186/s40478-019-0763-x
PMCID: PMC6617605
PMID: 31288852 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare that they have no competing 
interests.